Study on diagnosis and treatment of Budd-Chiari syndrome in China based on CO-word analysis_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

ZHANG Jiawei , CHEN Xiaoxiao ,  LU Zhaojun

Department of Epidemiology and Health Statistics, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu 221000, P. R. China;

Corresponding author：

LU Zhaojun, Email: L23zj@163.com

Keywords：

Budd-Chiari syndrome; Co-word analysis; keyword network; frequency; research hotspot

DOI：

10.7507/1007-9424.201906040

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective The purpose of this study is to apply the method of CO-word analysis to the evidence-based study of the diagnosis and treatment of Budd-Chiari syndrome (BCS), to understand the trend of BCS research in China and to explore the hot spots of BCS in recent years, and to provide new evidence-based data for the clinical practice and experimental research of BCS in China.Methods In the Wanfang database, CNKI, and VIP retrieval platform, " Budd-Chiari syndrome” was used as the key word or title. According to the publication time, it was divided into before 1998 (study group 1), 1999–2008 (study group 2), and 2009–2018 years (study group 3). The relationship matrix was established by using the Netdraw tool in Ucinet6.0, and the common words were plotted with the Netdraw tool. The word relation network was used to get the analysis chart of the relation of the word.Results This study found that, Budd-Chiari syndrome, inferior vena cava, hepatic vein, inferior vena cava obstruction, and syndrome were the most frequently used keywords in the study group 1. Budd-Chiari syndrome, inferior vena cava, hepatic venous, interventional therapy, and patients were the most frequent keywords in the study group 2. In the study group 3, Budd-Chiari syndrome, interventional therapy, inferior vena cava, hepatic vein, and patient were the most frequent keywords.Conclusions Hepatic vein type and inferior vena cava type have became a research hotspot in recent years, and the thrombosis mechanism is one of the directions for domestic scholars to study the etiology of BCS. The diagnosis and classification of BCS depend on color doppler ultrasound technology. Many studies focus on the differential diagnosis of BCS and cirrhosis.

Citation： ZHANG Jiawei, CHEN Xiaoxiao, LU Zhaojun. Study on diagnosis and treatment of Budd-Chiari syndrome in China based on CO-word analysis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(1): 75-81. doi: 10.7507/1007-9424.201906040 Copy

1.	汪忠镐, 李震. 布加综合征诊治历史、现状和发展趋势. 中国实用外科杂志, 2015, 35(12): 1261-1263.
2.	Ollivier-Hourmand I, Allaire M, Goutte N, et al. The epidemiology of Budd-Chiari syndrome in France. Dig Liver Dis, 2018, 50(9): 931-937.
3.	Afredj N, Guessab N, Nani A, et al. Aetiological factors of Budd-Chiari syndrome in Algeria. World J Hepatol, 2015, 7(6): 903-909.
4.	Wu Y, Jin X, Xue Y. Evaluation of research topic evolution in psychiatry using co-word analysis. Medicine (Baltimore), 2017, 96(25): e7349.
5.	党晓卫, 李路豪, 李林, 等. 布加综合征临床分型在其治疗中的应用价值. 中华消化外科杂志, 2016, 15(7): 696-701.
6.	Liu L, Qi XS, Zhao Y, et al. Budd-Chiari syndrome: current perspectives and controversies. Eur Rev Med Pharmacol Sci, 2016, 20(15): 3273-3281.
7.	中国医师协会腔内血管学专业委员会腔静脉阻塞专家委员会. 布-加综合征亚型分型的专家共识. 临床肝胆病杂志, 2017, 33(7): 1229-1235.
8.	Khan F, Armstrong MJ, Mehrzad H, et al. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther, 2019, 49(7): 840-863.
9.	Qi X, Han G, Guo X, et al. Review article: the aetiology of primary Budd-Chiari syndrome-differences between the West and China. Aliment Pharmacol Ther, 2016, 44(11-12): 1152-1167.
10.	Okuda K. Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol, 2001, 16(11): 1179-1183.
11.	林薇, 曾维政, 汤善宏, 等. 布加综合征病因学总结. 四川医学, 2016, 37(6): 693-696.
12.	吴磊, 张雪, 陈启鸿, 等. 磁共振成像与数字减影造影诊断布加综合征下腔静脉病变的比较. 中华肝胆外科杂志, 2017, 23(6): 361-364.
13.	Van Wettere M, Bruno O, Rautou PE, et al. Diagnosis of Budd-Chiari syndrome. Abdom Radiol (NY), 2018, 43(8): 1896-1907.
14.	李曦, 彭汇涓, 沙晓溪, 等. 彩色多普勒超声在布-加综合征诊断及分型中的价值. 川北医学院学报, 2013, 28(4): 359-361.
15.	Hak JF, Dabadie A, Hery G, et al. Doppler ultrasound in the diagnosis of Budd-Chiari syndrome in children after split liver transplantation. Diagn Interv Imaging, 2018, 99(10): 663-668.
16.	管中华. 彩超检测肝硬化与布-加综合征的对比研究. 饮食保健, 2017, 4(14): 18-19.
17.	李震, 丁鹏绪, 汪忠镐. 布加综合征的规范化治疗. 中国血管外科杂志: 电子版, 2013, 5(3): 27-29.
18.	He F, Zhao H, Dai S, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins. Sci Rep, 2016, 6: 36380.
19.	黄崇青, 虞冠锋, 黄景勇. 血管内介入治疗肝后段下腔静脉闭塞型布加综合征1例. 浙江医学, 2017, 39(14): 1223-1236.
20.	王朝阳, 任建庄, 韩新巍, 等. 经颈静脉肝内门体分流术联合经导管溶栓治疗肝静脉广泛闭塞型巴德-吉亚利综合征合并急性门静脉血栓的临床疗效. 中华消化杂志, 2017, 37(10): 661-665.
21.	Kucukay F, Akdogan M, Bostanci EB, et al. Percutaneous transluminal angioplasty for complete membranous obstruction of suprahepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol, 2016, 39(10): 1392-1399.
22.	于士龙, 王徽, 林易圣, 等. 肝静脉、下腔静脉球囊扩张、支架置入术治疗下腔静脉闭塞型布-加综合征. 实用医学杂志, 2013, 29(22): 3681-3683.
23.	Wei X, Hao X, Da-Hai Y, et al. Analysis of interventional treatments of Budd-Chiari Syndrome and the related complications: a study of 1 006 cases. Panminerva Med, 2013, 55(4): 371-376.
24.	Khan F, Mehrzad H, Tripathi D. Timing of transjugular intrahepatic portosystemic stent-shunt in Budd-Chiari syndrome: a UK hepatologist’s perspective. J Transl Int Med, 2018, 6(3): 97-104.
25.	汤波, 余朝文, 唐文波. 肝静脉下腔静脉 CTV 成像在布加综合征诊断与治疗方式选择中的价值. 中国普通外科杂志, 2016, 25(1): 143-146.
26.	Qi XS, Ren WR, Fan DM, et al. Selection of treatment modalities for Budd-Chiari Syndrome in China: a preliminary survey of published literature. World J Gastroenterol, 2014, 20(30): 10628-10636.

1. 汪忠镐, 李震. 布加综合征诊治历史、现状和发展趋势. 中国实用外科杂志, 2015, 35(12): 1261-1263.
2. Ollivier-Hourmand I, Allaire M, Goutte N, et al. The epidemiology of Budd-Chiari syndrome in France. Dig Liver Dis, 2018, 50(9): 931-937.
3. Afredj N, Guessab N, Nani A, et al. Aetiological factors of Budd-Chiari syndrome in Algeria. World J Hepatol, 2015, 7(6): 903-909.
4. Wu Y, Jin X, Xue Y. Evaluation of research topic evolution in psychiatry using co-word analysis. Medicine (Baltimore), 2017, 96(25): e7349.
5. 党晓卫, 李路豪, 李林, 等. 布加综合征临床分型在其治疗中的应用价值. 中华消化外科杂志, 2016, 15(7): 696-701.
6. Liu L, Qi XS, Zhao Y, et al. Budd-Chiari syndrome: current perspectives and controversies. Eur Rev Med Pharmacol Sci, 2016, 20(15): 3273-3281.
7. 中国医师协会腔内血管学专业委员会腔静脉阻塞专家委员会. 布-加综合征亚型分型的专家共识. 临床肝胆病杂志, 2017, 33(7): 1229-1235.
8. Khan F, Armstrong MJ, Mehrzad H, et al. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther, 2019, 49(7): 840-863.
9. Qi X, Han G, Guo X, et al. Review article: the aetiology of primary Budd-Chiari syndrome-differences between the West and China. Aliment Pharmacol Ther, 2016, 44(11-12): 1152-1167.
10. Okuda K. Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol, 2001, 16(11): 1179-1183.
11. 林薇, 曾维政, 汤善宏, 等. 布加综合征病因学总结. 四川医学, 2016, 37(6): 693-696.
12. 吴磊, 张雪, 陈启鸿, 等. 磁共振成像与数字减影造影诊断布加综合征下腔静脉病变的比较. 中华肝胆外科杂志, 2017, 23(6): 361-364.
13. Van Wettere M, Bruno O, Rautou PE, et al. Diagnosis of Budd-Chiari syndrome. Abdom Radiol (NY), 2018, 43(8): 1896-1907.
14. 李曦, 彭汇涓, 沙晓溪, 等. 彩色多普勒超声在布-加综合征诊断及分型中的价值. 川北医学院学报, 2013, 28(4): 359-361.
15. Hak JF, Dabadie A, Hery G, et al. Doppler ultrasound in the diagnosis of Budd-Chiari syndrome in children after split liver transplantation. Diagn Interv Imaging, 2018, 99(10): 663-668.
16. 管中华. 彩超检测肝硬化与布-加综合征的对比研究. 饮食保健, 2017, 4(14): 18-19.
17. 李震, 丁鹏绪, 汪忠镐. 布加综合征的规范化治疗. 中国血管外科杂志: 电子版, 2013, 5(3): 27-29.
18. He F, Zhao H, Dai S, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins. Sci Rep, 2016, 6: 36380.
19. 黄崇青, 虞冠锋, 黄景勇. 血管内介入治疗肝后段下腔静脉闭塞型布加综合征1例. 浙江医学, 2017, 39(14): 1223-1236.
20. 王朝阳, 任建庄, 韩新巍, 等. 经颈静脉肝内门体分流术联合经导管溶栓治疗肝静脉广泛闭塞型巴德-吉亚利综合征合并急性门静脉血栓的临床疗效. 中华消化杂志, 2017, 37(10): 661-665.
21. Kucukay F, Akdogan M, Bostanci EB, et al. Percutaneous transluminal angioplasty for complete membranous obstruction of suprahepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol, 2016, 39(10): 1392-1399.
22. 于士龙, 王徽, 林易圣, 等. 肝静脉、下腔静脉球囊扩张、支架置入术治疗下腔静脉闭塞型布-加综合征. 实用医学杂志, 2013, 29(22): 3681-3683.
23. Wei X, Hao X, Da-Hai Y, et al. Analysis of interventional treatments of Budd-Chiari Syndrome and the related complications: a study of 1 006 cases. Panminerva Med, 2013, 55(4): 371-376.
24. Khan F, Mehrzad H, Tripathi D. Timing of transjugular intrahepatic portosystemic stent-shunt in Budd-Chiari syndrome: a UK hepatologist’s perspective. J Transl Int Med, 2018, 6(3): 97-104.
25. 汤波, 余朝文, 唐文波. 肝静脉下腔静脉 CTV 成像在布加综合征诊断与治疗方式选择中的价值. 中国普通外科杂志, 2016, 25(1): 143-146.
26. Qi XS, Ren WR, Fan DM, et al. Selection of treatment modalities for Budd-Chiari Syndrome in China: a preliminary survey of published literature. World J Gastroenterol, 2014, 20(30): 10628-10636.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Study on diagnosis and treatment of Budd-Chiari syndrome in China based on CO-word analysis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content